November 4, 2021 Clinical Research AstraZeneca applies for approval of antibody treatment that provides passive immunity against COVID-19 for up to a year according to the press release. Indicated for vulnerable people who are immunocompromised or who have not responded to the vaccine.
November 3, 2021 Clinical Research Pfizer COVID vaccine approved in US for children 5 to 11 yo. Health Canada completing its review.
October 28, 2021 Clinical Research Neuropathologist report identifies other causes of mystery illness cluster in New Brunswick. No new illness discovered. Demonstrates the importance of taking the time to evaluate the evidence before rushing to judgement.
October 27, 2021 Clinical Research Manitoba breakthrough infection data reviews the incidence by age and severity. Older people with chronic disease most at risk. Overall, compared to unvaccinated, 3% of all COVID deaths over last 10 months were amongst the fully vaccinated. #VaccinesWork
September 28, 2021 Allergy/Immunology Researchers start the trek to figure out the biological mechanism how COVID infections lead to autoimmune disease even after recovery. First clues found that may lead to understanding Long-COVID. More to come. #GoScience #VaccinesWork
September 27, 2021 Clinical Research Retracted Canadian study that reported 1/1000 risk of myocarditis from mRNA vaccine weaponized by anti-vaccination websites despite data correction by the authors to 1/25,000. Review system worked to uncover error but damage now done.
September 24, 2021 Clinical Research If you are fully vaccinated, you are not as likely to spread the Coronavirus compared to the unvaccinated. #vaccineswork
September 21, 2021 Clinical Research Pfizer to provide COVID vaccine trial data covering 5 to 11 year-olds to Health Canada for review and authorization. Company press releases are one thing but proper evaluation and scrutiny of the evidence is required.
September 9, 2021 Clinical Research Latest information indicates that booster shots are not needed for most Canadians with several important exceptions. Science, like time is not static, and will help determine if this recommendation will change over time. #VaccinesWork #GoScience
August 23, 2021 Allergy/Immunology AstraZeneca is soon to publish results from its pre-exposure prophylaxis trial about anti-Covid antibodies given IM to people with comorbid states that reduce the immune response from vaccines. Reduced severe symptomatic risk (relative) by 77%.